Francesco de Rubertis, Director at Centessa Pharmaceuticals plc (CNTA), bought 2,486,990 shares at $20.00 ($12.0M) on 2021-06-02, disclosed to the SEC on 2021-06-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,886,990 | $0 | 0.0% |
| 2 | $20.00 | 13,923 | $278K | 2.3% |
| 3 | $20.00 | 586,077 | $11.7M | 97.7% |
| Total | $4.83 avg | 2,486,990 | $12.0M | 100% |
| Filing → |
| CNTA | BUY | 2021-11-30 | $1.6M | — | Filing → |
| NERV | SELL | 2016-08-12 | $10.0M | — | Filing → |
| NERV | BUY | 2015-03-20 | $975K | — | Filing → |